INTERPACE BIOSCIENCES, INC.·4

Jan 24, 4:30 PM ET

Richard Gregory 4

4 · INTERPACE BIOSCIENCES, INC. · Filed Jan 24, 2020

Insider Transaction Report

Form 4
Period: 2020-01-22
Richard Gregory
Chief Commercial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2020-01-22+7,5007,500 total
    Exercise: $8.18Exp: 2030-01-22Common Stock (7,500 underlying)
Holdings
  • Common Stock

    84,169
Footnotes (1)
  • [F1]The stock option is eligible to vest and become exercisable in equal installments on each of the first three anniversaries of the date of grant, subject to the reporting person's continued service with the Issuer through the applicable vesting dates.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT